Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine vs Chloroquine in Uncomplicated P. Knowlesi Malaria
NCT02001012Phase 3Completed
- Sponsor
- Menzies School of Health Research
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artemether + lumefantrine in Plasmodium knowlesi malaria (Pk), sponsored by Menzies School of Health Research. Started Jan 2014; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Plasmodium knowlesi malaria (Pk)
Beyond the preview
Go deeper on NCT02001012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001012.